Israel's Nova Q4 revenue beats on Optical portfolio strength

Reuters
Feb 12
Israel's Nova Q4 revenue beats on Optical portfolio strength

Overview

  • Israel metrology solutions provider's Q4 revenue up 14% yr/yr, beating analyst expectations

  • Adjusted EPS for Q4 beat analyst expectations

  • Company's metrology portfolio selected by a leading logic customer for CMP applications

Outlook

  • Nova expects Q1 2026 revenue between $222 mln and $232 mln

  • Company anticipates Q1 2026 GAAP EPS between $1.90 and $2.02

  • Nova projects Q1 2026 non-GAAP EPS between $2.13 and $2.25

Result Drivers

  • METROLOGY PORTFOLIO - Nova's Integrated Metrology portfolio was selected by a leading logic customer for CMP applications in Gate-All-Around processes

  • RECORD SALES - Record sales in Optical, Materials, and Chemical Metrology portfolios driven by demand for unique solutions for critical applications and market share gains

  • AI DEMAND - Record sales for Gate-All-Around, DRAM, and Advanced Packaging processes were driven by demand for AI

Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q4 Revenue

Beat

$222.62 mln

$220.33 mln (6 Analysts)

Q4 Adjusted EPS

Beat

$2.14

$2.12 (7 Analysts)

Q4 EPS

$1.94

Q4 Adjusted Net Income

Slight Beat*

$72.24 mln

$71.85 mln (6 Analysts)

Q4 Net Income

$64.89 mln

*Applies to a deviation of less than 1%; not applicable for per-share numbers.

Analyst Coverage

  • The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 6 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"

  • The average consensus recommendation for the semiconductors peer group is "buy"

  • Wall Street's median 12-month price target for Nova Ltd is $380.00, about 20.1% below its February 11 closing price of $475.83

  • The stock recently traded at 49 times the next 12-month earnings vs. a P/E of 37 three months ago

Press Release: ID:nPn7ZNx4Qa

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10